With all the talk about COVID vaccinations, cancer patients have to be asking what it means for them. And aside from some general reassurances, there is a lot we don’t know about how effective those vaccines will be in patients with cancer. What we do know that many are at risk of severe adverse outcomes should they become infected with the virus itself and vaccines are one among several strategies to keep patients with cancer safe from the ravages of COVID and its consequences. There are a couple of important points to keep in mind when we talk about patients… Read More »COVID-19, Vaccines, and Cancer: We Don’t Have All The Answers
Health equity has been top of mind for many this past year, in large part because of the impact of the pandemic especially on people of color and underserved communities. Now that we recognize that health equity is not a reality for far too many, the question remains what are we actually going to do to make certain that everyone has the tools they need to pursue a life of health and healthy behaviors? And more specifically, what are we going to do in the cancer care sphere—from prevention to diagnosis to treatment to end-of-life care—to address the glaring inequities… Read More »An Actionable Framework to Address Cancer Care Disparities: A Call To Action
Getting Back To Cancer Screening: It’s Time To Give Priority To Those Most In Need, Not Those With The Loudest Voice
“How will be certain coming out the pandemic that those who should be a priority for cancer screenings based on risk and need in fact get to the head of the line? And how will we be certain that those who lack voice in the healthcare system are heard and their needs addressed?” That was the question I asked frequently a year ago as we went into the initial shutdown phase as a result of COVID-19. It was a time when there was fear and a lack of understanding about the pandemic, when resources had to be shifted to acute… Read More »Getting Back To Cancer Screening: It’s Time To Give Priority To Those Most In Need, Not Those With The Loudest Voice
It is hard to believe it was just a year ago when all of this started. And now to realize that after everything that we have gone through we are still not near the end of the journey. One year ago I had just started having conversations with knowledgeable colleagues about the threat of this new potentially fatal virus. It was the beginning with cases of a new viral illness reported out of China, a killer virus that was still very much a theoretical threat of what could happen here in the United States. The back-of-the-envelope COVID-19 death projections we… Read More »The Tragic Anniversary of COVID-19
Cancer advocacy is not often top of mind, even for patients and families facing active diagnoses and treatments for cancer. However, with the added impact of COVID-19 on our health and well being, advocacy and service in the cancer space is becoming more important than ever. That is one of the messages that came from a webinar I participated in this morning on “Cancer Care Patient Advocacy Perspectives” as part of a series of discussions being presented over the course of several months by the Association for Value Based Cancer Care. Organizations providing advocacy and service to those with cancer… Read More »Cancer Advocacy: A Precious Resource In A Time Of Immense Needs
16 million cancer survivors in the United States, growing every year. Success stories we never would have imagined even a decade ago. And yet, when it comes to genuinely understanding the impacts of cancer treatments and what happens over the long term to young and older survivors alike, we are woefully uniformed and under-prepared—and as a nation don’t have a unified plan to address the issue. That’s my take away nugget from a two day workshop just completed on “Addressing the Adverse Consequences of Cancer Treatment,” convened by the National Cancer Policy Forum, which is part of the National Academies… Read More »It’s Time To Address The Needs Of Cancer Survivors
Hydroxychloroquine has become a part of the COVID story that will not go away. And with another research study reported today in JAMA showing no benefit of the drug in hospitalized patients with COVID-19, the journal asks the fundamental question: Why do we continue to believe this drug has benefit in treating this pandemic illness, and why won’t science prevail? To which we respond: Why are we surprised???? The study, performed by a clinical trial collaborative under the guidance of the National Heart and Lung Institute of the National Institutes of Health included 479 patients in 34 hospitals around the… Read More »Hydroxychlorqine for COVID-19: Time To Move On?
No one really wants to say this about national political leadership, especially in a time of serious nationwide distress and even moreso at a time of heightened political tension and presidential elections, lest one’s comments be dismissed as being politically motivated. However given the events of the past months and especially the past few days, it must be said: Our national (and some state) political leaders are demonstrating a wanton, deliberate and callous disregard for truth and for science, and as a result we are now entering a period of intense national emergency leading to avoidable illness, death and potential… Read More »A Wanton, Deliberate and Callous Disregard for the Truth and Science Regarding COVID-19
We have had a bit of a debate in this country whether or not we had an effective response to the corona virus pandemic. Now new data shows that not only have we done a poor job of controlling COVID-19 infections and deaths but our outcomes have been among the worst in the developed world. That’s hard to believe, but it is true. At least that’s what the data shows. The research report published yesterday in JAMA starts with the comment that “The US has experienced more deaths from coronavirus disease 2019 (COVID-19) than any other country and has one… Read More »The United States Leads The Developed World In COVID-19 Deaths. Really.
The news early this morning that the President and the First Lady have both been diagnosed with COVID-19 infections has been devastating. And for the next two weeks or so, although we pray otherwise, the journey may be difficult. We just don’t know. Many of us are now asking what those two weeks might bring. Unfortunately, there is no clear answer. No matter the fact that everyone will have their “take” on what is going to happen, the reality is that no one knows. I have learned from a lot of experience commenting in the public space about illnesses and… Read More »COVID And The President: What We Can Expect